City Therapeutics

CTYNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.127 B

$22.40 +24.44%

Close of 19 Oct 2026

As of 19 Oct 2026, City Therapeutics (CTY) has a market capitalization of $1.13B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 501 →

#139Opko HealthOPK$1.14B
#140Damora TherapeuticsDMRA$1.14B
#141City TherapeuticsCTY$1.13B
#142Bicara TherapeuticsBCAX$1.11B
#143Amphastar PharmaceuticalsAMPH$1.10B

Insiders buying

All insider buying →

2 open-market purchases by officers and directors of City Therapeutics, worth $6.12M. Grants and option exercises are excluded.

Robert Nelsen$3.06M
170,000 shares at $18.00 on 19 Oct 2026 · filed 19 Oct 2026
ARCH Venture Fund XII, L.P., ARCH Venture Partners XII, L.P., ARCH Venture Partners XII, LLC, Kristina Burow, Keith Crandell, Steven Gillis$3.06M
170,000 shares at $18.00 on 19 Oct 2026 · filed 19 Oct 2026

What if City Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.7T

$569,427.70

Per share 25,421× higher

Bitcoin $1.64T

$32,543.23

Per share 1,453× higher

Nvidia $5.16T

$102,529.29

Per share 4,577× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for City Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 20 Oct 2026. Read the methodology.